IFNA1 and cancer: Significantly, inhibition of DNA-PK with AZD7648 resulted in IFN-dependent inhibition of tumor growth following IR in immune competent mouse models, indicating that inhibition of DNA-PK in combination with radiotherapy could lead to durable immune-mediated tumor control in cancer patients (277).